Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503).

Satoru IwasaNatsuko OkitaAya KuchibaGakuto OgawaMamiko KawasakiKenichi NakamuraHirokazu ShojiYoshitaka HonmaAtsuo TakashimaKen KatoTetsuya HamaguchiNarikazu BokuYasuhide Yamada

Published in: ESMO open (2021)

UMIN-CTR, UMIN000023446 and JAMCCT-CTR, JMA-IIA00261.

Keyphrases

phase ii study
metastatic colorectal cancer
locally advanced
open label
rectal cancer
randomized controlled trial
placebo controlled